Article in Clinical and public health guidelines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
20 authors.
Cindy SternHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-0924-5042
Danielle PollockHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-6604-0609
Timothy BarkerHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-6897-814X
Grace McKenzie HollandHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-6260-098X
Sabira HasanoffHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0001-7246-0485
Nipun ShresthaHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0003-3542-8130
Ines SemendricHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-7099-929X
Lemma Negesa BultoHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0001-9528-5595
Sitasma SharmaHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-9596-0623
Anna FragkoudiHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0001-7660-7835
Sebastian Cole Facchin-YoungHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0009-0009-2518-3521
Abigail Molly Day-SharmanHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0009-0001-7400-8211
Lara StolleryHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0009-0004-3624-3466
Camille SchubertAdelaide Health Technology Assessment (AHTA), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0003-0828-1612
Tracy MerlinAdelaide Health Technology Assessment (AHTA), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-7293-4262
Steve VucicBrain and Nerve Research Centre, Concord Clinical School The University of Sydney Sydney Australia.
Jo WhitehouseMND Victoria Canterbury Australia.
Zachary MunnHealth Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, Faculty of Health and Medical Sciences The University of Adelaide Adelaide Australia.ORCID https://orcid.org/0000-0002-7091-5842
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Introduction: Motor neurone disease (MND) is a rare but devastating neurodegenerative condition that results in progressive muscle weakness, disability, and eventual respiratory failure. In Australia, the impact of MND is significant, and there is a pressing need for a high-quality, locally relevant guideline to support equitable, person-centred care. Questions: This guideline aims to address key clinical and care-related questions that arise across the MND trajectory. It will identify the most pressing topics and uncertainties in MND management through interest holder consultation and structured prioritisation. Methods: The guideline will be developed using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and will align with standards set by the National Health and Medical Research Council (NHMRC) and the Guidelines International Network (GIN). Governance will include a multi-tiered structure with lived experience representation. Implementation planning and evaluation will be integrated throughout, with a planned transition to a living guideline model supported by an ongoing evidence surveillance strategy.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Protocol for the Development of The Australian Motor Neurone Disease (MND) Guideline. · full record | OpenQuestion